Exodus Point Capital Management, LP Myriad Genetics Inc Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Myriad Genetics Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 79,066 shares of MYGN stock, worth $1.97 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
79,066
Previous 17,960
340.23%
Holding current value
$1.97 Million
Previous $288,000
485.42%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MYGN
# of Institutions
191Shares Held
94.2MCall Options Held
280KPut Options Held
14.3K-
Black Rock Inc. New York, NY14.9MShares$370 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$250 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.06MShares$201 Million0.03% of portfolio
-
Camber Capital Management LP Boston, MA7.64MShares$190 Million3.99% of portfolio
-
State Street Corp Boston, MA5.4MShares$135 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2.01B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...